United States

People: ZELTIQ Aesthetics Inc (ZLTQ.O)

ZLTQ.O on Nasdaq

17 Feb 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Schiff, Andrew 

Dr. Andrew N. Schiff, M.D., is an Independent Director of Zeltiq Aesthetics Inc., since July 2010. Dr. Schiff joined Aisling Capital in September of 1999 and has served as a Managing Partner since 2002. Prior to joining Aisling Capital, Dr. Schiff practiced internal medicine at The New York Presbyterian Hospital where he maintains his position as a Clinical Assistant Professor of Medicine. In addition to ZELTIQ, Dr. Schiff served as a director of Agile Therapeutics, Inc., a publicly-traded company, until February 2016, and currently serves as a director of a number of private companies. Dr. Schiff received his M.D. from Cornell University Medical College, his M.B.A. from Columbia University, and his B.S. with honors in Neuroscience from Brown University.

Basic Compensation

Total Annual Compensation, USD 57,500
Restricted Stock Awards, USD 174,952
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 232,452

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --